Patients 65 years of age or older represent the fastest-growing demographic group added to the U.S. heart transplant (HT) list.
View Article and Find Full Text PDFBackground: Heart transplantation (HT) survival and waitlist times are established outcome metrics. Patient-centered HT outcomes are insufficiently characterized. This study evaluates the role of days alive and outside the hospital (DAOH) as a candidate patient-centered HT performance measure.
View Article and Find Full Text PDFThe 15th Annual Report from The Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support includes 29,634 continuous-flow left ventricular assist devices from the 10-year period between 2014 and 2024. The outcomes reported here demonstrate continued improved survival in the current era of fully magnetically levitated devices, with a significantly higher 1-year (85.7% vs 78.
View Article and Find Full Text PDFJ Heart Lung Transplant
January 2025